Archive for the ‘Hospital Clínic de Barcelona’ Category

Monday January 16th, 2017

Hospital Clinic-IDIBAPS leads a European project to fight against cirrhosis within the Horizon 2020 program

Hospital Clínic-IDIBAPS is leading a European project to evaluate the efficacy of treatment with the combination of rifaximin, an antibiotic that modulates the intestinal microbiome, and statins in patients with advanced cirrhosis. The project, called LIVERHOPE, will also focuse on the search for biomarkers of the disease. LIVERHOPE is coordinated by Dr. Pere Ginès, head of the Hepatology Department of the Hospital Clínic and of the team of Mechanisms of liver diseases and complications of cirrhosis of IDIBAPS, and a total of 16 institutions are participating among clinical centers, universities and European companies. This project is part of the Horizon 2020 European research and innovation framework program and it is endowed with a budget of 6 million euros.

Read the rest of this entry »

Comments Closed
Tuesday January 10th, 2017

Transplant Biomedical receives an economical injection to develop an organ preservation device

Transplant Biomedical, one of the two spin-offs arising from IDIBAPS, will receive a maximum of 2.5 million euros to carry out the clinical phase of a medical device intended to improve the preservation and transport of kidneys and livers for transplantation. This economic injection is the result of an agreement with Caixa Capital Risc and Kereon Partners, the company founded, among others, by Carmen Peralta, coordinator of the group Strategies for the protection of hepatic injury induced by ischemia-reperfusion. Read the rest of this entry »

Comments Closed
Thursday December 22nd, 2016

Blanca Molins receives the Julián García Sánchez award for research on vision issues

Blanca Molins rep el premi Julián García Sánchez de recerca en temes de la visió Read the rest of this entry »

Comments Closed
Thursday December 15th, 2016

New cellular reprogramming technique counters hallmarks of aging

Scientists from Salk Institute for Biological Studies showed that One clue to halting or reversing aging lies in the study of cellular reprogramming, a process in which the expression of four genes known as the Yamanaka factors allows scientists to convert any cell into induced pluripotent stem cells (iPSCs) Like embryonic stem calls, iPSCs are capable of dividing indefinitely and becoming any cell type present in our body. Dr. Juan Carlos Izpisúa Belmonte, professor in Salk’s Gene Expression Laboratory, is the senior author of the paper, published in Cell, in which also participated Dr. Josep Maria Campistol, CEO and nephrologist in Hospital Clínic, and researcher in IDIBAPS. Scientists from Universidad Católica de Murcia, among others, have also been involved. Read the rest of this entry »

Comments Closed
Wednesday December 14th, 2016

CaixaImpulse selects two IDIBAPS projects to promote technology transfer

On Monday, December 12, Palau Macaya hosted the presentation of the selected projects in the second edition of CaixaImpulse, two of which are from IDIBAPS.

Read the rest of this entry »

Comments Closed
Wednesday November 30th, 2016

Hospital Clínic will implement a new genomic test to predict response to treatment in breast cancer

Researchers from Hospital Clínic and IDIBAPS lead an international study in which they have developed a genomic test to predict the response to chemotherapy in breast cancer. Hospital Clínic of Barcelona will be the first hospital in the world to implement this third generation test. This test is based on the data produced by the second-generation test PAM50, and for which Hospital Clínic is one of the reference centers. The article, published today in the journal Clinical Cancer Research, has been coordinated by Dr. Aleix Prat, Head of the Clinical Oncology Department at Hospital Clínic, the Translational genomics and targeted therapeutics in solid tumors research team at IDIBAPS and the Translational Genomics group of the Vall d’Hebron Institute of Oncology (VHIO). The study has involved several hospitals in Spain within the GEICAM breast cancer co-operative group, researchers from the University of North Carolina (USA), the Royal Marsden Foundation Trust in London, the University of Otago (New Zealand) and The University of Edinburgh (Scotland).

Read the rest of this entry »

Comments Closed
Page 5 of 58« First...34567...Last »